Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD
On November 12, Scotiabank analyst Louise Chen began coverage on ten large-cap biopharma companies and shared an “out-of-consensus” positive view on the sector, according...







